National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI

Understanding Cancer Series: Cancer Genomics
< Back to Main
In English     En español
    Posted: 01/28/2005    Reviewed: 09/01/2006
Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Cancer Genomics

      Slide Number and Title
  1. What Is the Human Genome?
  2. Cancer Genomics
  3. A Sample Human Genome
  4. Genes: Keepers of the Code
  5. Noncoding Regions
  6. Genes to mRNA to Proteins
  7. RNA Processing Before Translation
  8. Triplet Code
  9. Mutations
  10. Mutations: Somatic and Germline
  11. Tumors Are Clonal
  12. Somatic Mutations
  13. Mitosis and Somatic Mutations
  14. Meiosis and Germline Mutations
  15. Recombination: Crossing Over
  16. De Novo Mutations
  17. Point Mutations
  18. Frameshift Mutations
  19. Splice-Site Mutations
  20. Regulatory Mutations
  21. SNPs: Frequently Occurring Genetic Variants
  22. Large Deletions or Insertions
  23. Example: Translocation of Bcr-Abl Genes
  24. Cancer-Associated Mutations
  25. Genotypes and Phenotypes
  26. Alleles
  27. Same Allele, Different Locus, Different Phenotype
  28. Different Locus, Different Allele, Same Phenotype
  29. Penetrance
  30. Factors Influencing Penetrance
  31. Age-Related Penetrance
     
  1. Epigenetic Factors and Penetrance
  2. Epigenetic Example: Methylation Alters Gene Expression
  3. Imprinting Alters Gene Expression
  4. Carrier Frequency
  5. Prevalence and Founder Effect
  6. Example: Founder Effect in Ashkenazi Jewish Population
  7. Mutations in Cancer Susceptibility Genes: BRCA1
  8. Mutations in Cancer Susceptibility Genes: BRCA2
  9. Autosomal Dominant Inheritance
  10. Examples of Dominantly Inherited Cancer Syndromes
  11. Cancer Susceptibility: Incomplete Penetrance and Phenocopies
  12. Example: BRCA1-Linked Hereditary Breast and Ovarian Cancer
  13. Example: BRCA2-Linked Hereditary Breast Cancer
  14. Autosomal Recessive Inheritance
  15. Some Recessively Inherited Cancer Syndromes
  16. X-Linked Inheritance
  17. Other Genetic Conditions Linked to Increased Cancer Risk
  18. Normal Cell Growth: The Cell Cycle
  19. Abnormal Cell Growth: Oncogenes
  20. Tumor Suppressor Genes
  21. Mutations in Tumor Suppressor Genes
  22. Two-Hit Hypothesis
  23. Loss of Heterozygosity
  24. Heterozygous Condition
  25. Repair Failure
  26. Cancer Susceptibility: Much Still Unknown
  27. Epigenetic Changes: Much Still Unknown
  28. Other Cancer-Associated Mutations: Much Still Unknown
  29. Other Cancer-Associated Mutations: Much Still Unknown (cont.)
  30. A Daunting Challenge

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov